Post by Merck

Name: We’re proud to announce the #FDA approvals of new immunotherapy-based treatment combinations for cer
Uploaded: 2026-06-25T11:02:04.742Z
Channel: Merck
Description: We’re proud to announce the #FDA approvals of new immunotherapy-based treatment combinations for certain adults with advanced triple-negative breast cancer (#TNBC). This milestone, in collaboration w

2,749,846 followers

We’re proud to announce the #FDA approvals of new immunotherapy-based treatment combinations for certain adults with advanced triple-negative breast cancer (#TNBC). This milestone, in collaboration with Gilead Sciences, is an important step forward in care for patients with this disease. Learn more: go.merck.com/~y66

Video Content